Kontafarma China Holdings Ltd (HK:1312) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Kontafarma China Holdings Limited has issued a clarification regarding an error in the title of Mr. Wang Feifei in their recent announcement. The correct title for Mr. Wang Feifei is ‘President’ rather than ‘Executive President’ as previously stated. The company confirms that apart from this correction, all other details in the original documents remain unchanged.
For further insights into HK:1312 stock, check out TipRanks’ Stock Analysis page.